跳至主要内容
临床试验/NL-OMON55197
NL-OMON55197招募中不适用

The role of glycosaminoglycans and macrophages in salt-sensitivity of blood pressure - SALT-3

Academisch Medisch Centrum0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All subjects:
  • - Men and women Between 18 and 75 years of age
  • - Office blood pressure <= 140/90 mmHg
  • - A body mass index <= 30 kg/m2
  • - Capable of giving written informed consent and able to comply with the
  • requirements and restrictions listed in the informed consent form
  • Microalbuminuric type 2 diabetes patients:
  • - Known with Diabetes Mellitus type 2
  • - Either albuminuria (20-200 mg/L in a morning urine sample / 30-300 mg/24 hrs)
  • - Stable renal function (eGFR 45-90 ml/min/1.73m2) with or without on stable
  • therapy with RAAS inhibiting agents
  • - HbA1c levels below 10.0% (86mmol/mol) during the 6 months preceding the study
  • Nondiabetic CKD patients
  • - Known with CKD stage 2 - 3a
  • - Stable renal function during the 6 months preceding the study (eGFR 45-90
  • ml/min/1.73m2) with or without on stable therapy with RAAS inhibiting agents
  • - Albuminuria (> >200 mg/L in a morning urine sample / 500 - 3000mg/24 hrs)

排除标准

  • - An office blood pressure >140/90 mmHg;
  • - A body mass index >30 kg/m2;
  • - Use of systemic corticosteroids;
  • - Use of NSAIDs > 2 times a week;
  • - A major illness in the past 3 months of any significant chronic medical
  • illness that the Investigator would deem unfavourable enrolment, including
  • chronic inflammatory diseases, excluding the diseases of interest (DM2 and CKD)
  • - A history of any type of malignancy within the past 5 years with the
  • expectation of successfully treated basal cell cancer of the skin;
  • - A history of any auto-immune disease ;
  • - A history of cardiovascular disease (in the past 6 months) defined as
  • documented coronary artery disease including myocardial infarction, (un-)stable
  • angina pectoris or acute coronary syndrome, percutaneous transluminal coronary
  • angioplasty, coronary artery bypass grafting, cerebrovascular disease including
  • ischemic and haemorrhagic stroke or a subarachnodial bleeding, or peripheral
  • artery disease including aortic aneurysmata;
  • - A history of eye surgery, glaucoma of retinal disorder;
  • - A history, within 3 years, of drug abuse (including benzodiazepines, opioids,
  • amphetamine, cocaine, THC, methamphetamine);
  • - A history of alcoholism and/or drinking more than 3 units of alcohol per day.
  • Alcoholism is defined as an average weekly intake of >21 units for males. One
  • unit is equivalent to 9 g of alcohol: a half-pint (~ 240mL) of beer, 1 glass
  • (125 mL) of wine or 1 (25ml) measure of spirits;
  • - Smoking or use of tobacco products less than 30 days ago;
  • - Any other issue that in opinion of the Investigator could be harmful to the
  • subject or compromise interpretation of the data.

研究者

相似试验